Work

A window of opportunity trial of atorvastatin in p53-mutant and p53 wild type malignancies.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps3165

Authors: Mohammad Telfah, Tomoo Iwakuma, Andres Bur, Lisa Shnayder, Terry Tsue, Mazin Mazin Al-Kasspooles, John Ashcraft, Benjamin Martin, Raed Moh'd Taiseer Al-Rajabi, Anup Kasi, Qamar J. Khan, Tara L. Lin, Anwaar Saeed, Stephen K. Williamson, Prabhakar Chalise, Andrew K. Godwin, Greg Reed, Sufi Thomas, Takefumi Komiya, Joaquina Celebre Baranda

Institutions: The University of Kansas Cancer Center, University of Kansas Medical Center, The University of Texas at San Antonio Health Science Center, Fox Chase Cancer Center, University of Kansas, Parkview Health

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947450223

Cites:

Cited by: 5

Related to: 10